In Win For Barr, Court Denies Tamoxifen Rehearing
Marking a victory for Barr Pharmaceuticals Inc. in a long-running case over authorized generics, the U.S. Court of Appeals for the Second Circuit has denied a bid for rehearing by a...To view the full article, register now.
Already a subscriber? Click here to view full article